REG - PureTech Health PLC - Transaction in Own Shares
25/10/2023 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231025:nRSY1721Ra&default-theme=true
RNS Number : 1721R PureTech Health PLC 25 October 2023
25 October 2023
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 24 October 2023
Number of ordinary shares purchased: 35,591
Highest price paid per share: 169.20p
Lowest price paid per share: 164.60p
Volume weighted average price paid per share: 166.14p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 15,750,875 ordinary
shares in treasury and has 273,717,284 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 273,717,284 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
24/10/2023 11:51:43 33 169.2 CHIX 00375148812TRLO0.1.1
24/10/2023 11:51:44 400 168.6 CHIX 00375148820TRLO0.1.1
24/10/2023 11:51:44 47 168.6 CHIX 00375148819TRLO0.1.1
24/10/2023 11:51:44 267 168.6 XLON 00375148822TRLO0.1.1
24/10/2023 11:51:44 651 168.6 XLON 00375148821TRLO0.1.1
24/10/2023 11:51:44 199 168.2 AQXE 00375148823TRLO0.1.1
24/10/2023 11:51:44 199 168.2 AQXE 00375148824TRLO0.1.1
24/10/2023 11:51:52 22 167.6 BATE 00375148848TRLO0.1.1
24/10/2023 11:51:58 45 167.6 BATE 00375148861TRLO0.1.1
24/10/2023 11:59:54 541 167.6 XLON 00375150155TRLO0.1.1
24/10/2023 11:59:54 836 167.6 XLON 00375150157TRLO0.1.1
24/10/2023 11:59:54 70 167.6 TRQX 00375150156TRLO0.1.1
24/10/2023 11:59:54 27 167.6 TRQX 00375150158TRLO0.1.1
24/10/2023 11:59:54 139 167.6 BATE 00375150160TRLO0.1.1
24/10/2023 11:59:54 351 167.6 BATE 00375150159TRLO0.1.1
24/10/2023 11:59:54 13 167.4 CHIX 00375150161TRLO0.1.1
24/10/2023 11:59:54 279 167.6 BATE 00375150162TRLO0.1.1
24/10/2023 11:59:54 434 167.4 CHIX 00375150163TRLO0.1.1
24/10/2023 11:59:57 199 168.6 AQXE 00375150167TRLO0.1.1
24/10/2023 12:00:03 38 166.8 AQXE 00375150184TRLO0.1.1
24/10/2023 12:00:36 161 166.8 AQXE 00375150366TRLO0.1.1
24/10/2023 12:01:31 447 166.4 CHIX 00375150417TRLO0.1.1
24/10/2023 12:33:23 414 166 CHIX 00375155615TRLO0.1.1
24/10/2023 12:33:23 127 166 CHIX 00375155616TRLO0.1.1
24/10/2023 12:33:23 138 166 XLON 00375155617TRLO0.1.1
24/10/2023 12:33:23 184 166 CHIX 00375155618TRLO0.1.1
24/10/2023 12:33:23 1239 166 XLON 00375155619TRLO0.1.1
24/10/2023 12:33:23 136 166 CHIX 00375155620TRLO0.1.1
24/10/2023 12:40:38 58 166 XLON 00375156846TRLO0.1.1
24/10/2023 12:40:51 42 166 XLON 00375156884TRLO0.1.1
24/10/2023 12:58:45 36 167.2 XLON 00375159488TRLO0.1.1
24/10/2023 13:08:10 489 167.2 XLON 00375161014TRLO0.1.1
24/10/2023 13:08:10 185 167.2 XLON 00375161015TRLO0.1.1
24/10/2023 13:16:37 281 167.8 XLON 00375162265TRLO0.1.1
24/10/2023 13:16:37 1096 167.8 XLON 00375162266TRLO0.1.1
24/10/2023 13:45:10 361 167.2 XLON 00375166826TRLO0.1.1
24/10/2023 13:45:10 50 167.2 XLON 00375166827TRLO0.1.1
24/10/2023 13:45:10 507 167.2 XLON 00375166828TRLO0.1.1
24/10/2023 13:45:10 418 167.2 BATE 00375166829TRLO0.1.1
24/10/2023 13:48:27 185 167 AQXE 00375167241TRLO0.1.1
24/10/2023 13:48:27 97 167 TRQX 00375167243TRLO0.1.1
24/10/2023 13:48:27 213 167 AQXE 00375167242TRLO0.1.1
24/10/2023 13:48:27 97 167 TRQX 00375167244TRLO0.1.1
24/10/2023 13:48:27 918 166.8 XLON 00375167245TRLO0.1.1
24/10/2023 13:48:27 57 166.6 CHIX 00375167247TRLO0.1.1
24/10/2023 13:48:27 33 166.6 CHIX 00375167246TRLO0.1.1
24/10/2023 13:48:27 357 166.6 CHIX 00375167248TRLO0.1.1
24/10/2023 13:59:54 259 166 BATE 00375168871TRLO0.1.1
24/10/2023 13:59:54 1377 166.4 XLON 00375168870TRLO0.1.1
24/10/2023 13:59:54 151 166 BATE 00375168873TRLO0.1.1
24/10/2023 13:59:54 8 166 BATE 00375168872TRLO0.1.1
24/10/2023 13:59:54 107 166 BATE 00375168874TRLO0.1.1
24/10/2023 14:00:44 67 166.4 XLON 00375169030TRLO0.1.1
24/10/2023 14:02:09 68 166 BATE 00375169197TRLO0.1.1
24/10/2023 14:02:16 142 166 XLON 00375169225TRLO0.1.1
24/10/2023 14:02:21 304 165.8 XLON 00375169232TRLO0.1.1
24/10/2023 14:02:51 1073 165.8 XLON 00375169310TRLO0.1.1
24/10/2023 14:18:29 97 165 TRQX 00375172897TRLO0.1.1
24/10/2023 14:18:29 265 165 XLON 00375172898TRLO0.1.1
24/10/2023 14:18:29 653 165 XLON 00375172899TRLO0.1.1
24/10/2023 14:33:23 419 164.6 XLON 00375177116TRLO0.1.1
24/10/2023 14:33:23 918 164.6 XLON 00375177115TRLO0.1.1
24/10/2023 14:58:08 154 165.6 XLON 00375187609TRLO0.1.1
24/10/2023 14:58:08 738 165.6 XLON 00375187610TRLO0.1.1
24/10/2023 14:58:34 23 165.6 XLON 00375187808TRLO0.1.1
24/10/2023 15:00:09 199 165.8 AQXE 00375188534TRLO0.1.1
24/10/2023 15:00:14 280 165.4 CHIX 00375188659TRLO0.1.1
24/10/2023 15:05:54 39 165.2 XLON 00375191129TRLO0.1.1
24/10/2023 15:08:11 10 165.2 XLON 00375192248TRLO0.1.1
24/10/2023 15:08:13 10 165.2 XLON 00375192266TRLO0.1.1
24/10/2023 15:08:16 10 165.2 XLON 00375192280TRLO0.1.1
24/10/2023 15:08:18 50 165.2 XLON 00375192289TRLO0.1.1
24/10/2023 15:08:21 620 165.2 XLON 00375192320TRLO0.1.1
24/10/2023 15:27:27 52 165.8 BATE 00375202891TRLO0.1.1
24/10/2023 15:27:27 199 166 AQXE 00375202890TRLO0.1.1
24/10/2023 15:27:27 114 165.8 CHIX 00375202892TRLO0.1.1
24/10/2023 15:27:27 366 165.8 BATE 00375202893TRLO0.1.1
24/10/2023 15:27:27 333 165.8 CHIX 00375202894TRLO0.1.1
24/10/2023 15:27:27 178 165.8 XLON 00375202895TRLO0.1.1
24/10/2023 15:27:27 281 165.8 XLON 00375202896TRLO0.1.1
24/10/2023 15:27:33 137 165.8 XLON 00375202943TRLO0.1.1
24/10/2023 15:29:30 250 165.8 XLON 00375204207TRLO0.1.1
24/10/2023 15:29:30 209 165.8 XLON 00375204208TRLO0.1.1
24/10/2023 15:29:33 121 165.8 XLON 00375204219TRLO0.1.1
24/10/2023 15:29:37 68 165.8 XLON 00375204240TRLO0.1.1
24/10/2023 15:34:28 987 166 XLON 00375206143TRLO0.1.1
24/10/2023 15:34:28 390 166 XLON 00375206144TRLO0.1.1
24/10/2023 15:36:34 138 165.8 XLON 00375207094TRLO0.1.1
24/10/2023 15:36:38 89 165.8 XLON 00375207130TRLO0.1.1
24/10/2023 15:36:41 79 165.8 XLON 00375207143TRLO0.1.1
24/10/2023 15:39:30 49 166 XLON 00375208524TRLO0.1.1
24/10/2023 15:39:36 28 166 XLON 00375208550TRLO0.1.1
24/10/2023 15:39:38 54 166 XLON 00375208558TRLO0.1.1
24/10/2023 15:41:21 222 165.8 BATE 00375209369TRLO0.1.1
24/10/2023 15:41:21 199 165.8 AQXE 00375209368TRLO0.1.1
24/10/2023 15:41:21 72 165.8 CHIX 00375209370TRLO0.1.1
24/10/2023 15:41:21 59 165.8 BATE 00375209371TRLO0.1.1
24/10/2023 15:41:37 137 165.8 BATE 00375209484TRLO0.1.1
24/10/2023 15:41:37 243 165.8 BATE 00375209486TRLO0.1.1
24/10/2023 15:41:37 455 165.8 CHIX 00375209485TRLO0.1.1
24/10/2023 15:41:37 87 165.8 CHIX 00375209487TRLO0.1.1
24/10/2023 15:41:37 459 165.8 XLON 00375209488TRLO0.1.1
24/10/2023 15:51:47 1377 165.4 XLON 00375214694TRLO0.1.1
24/10/2023 15:51:48 97 165.4 TRQX 00375214696TRLO0.1.1
24/10/2023 15:51:48 418 165.4 BATE 00375214695TRLO0.1.1
24/10/2023 16:01:03 1112 164.8 XLON 00375219951TRLO0.1.1
24/10/2023 16:13:05 4 165.4 TRQX 00375224933TRLO0.1.1
24/10/2023 16:14:58 2 165.4 AQXE 00375225846TRLO0.1.1
24/10/2023 16:16:39 18 165.4 XLON 00375226648TRLO0.1.1
24/10/2023 16:16:39 304 165.4 XLON 00375226649TRLO0.1.1
24/10/2023 16:16:39 414 165.4 XLON 00375226650TRLO0.1.1
24/10/2023 16:16:43 136 165.4 XLON 00375226691TRLO0.1.1
24/10/2023 16:17:10 154 165.4 XLON 00375226859TRLO0.1.1
24/10/2023 16:18:02 153 165.4 XLON 00375227216TRLO0.1.1
24/10/2023 16:18:02 198 165.4 XLON 00375227217TRLO0.1.1
24/10/2023 16:18:02 1331 165.4 XLON 00375227218TRLO0.1.1
24/10/2023 16:18:23 46 165.2 CHIX 00375227409TRLO0.1.1
24/10/2023 16:18:23 401 165.2 CHIX 00375227410TRLO0.1.1
24/10/2023 16:18:46 197 165 AQXE 00375227637TRLO0.1.1
24/10/2023 16:18:46 29 165 XLON 00375227638TRLO0.1.1
24/10/2023 16:18:48 67 165 XLON 00375227646TRLO0.1.1
24/10/2023 16:18:48 153 165 XLON 00375227648TRLO0.1.1
24/10/2023 16:18:48 210 165 XLON 00375227647TRLO0.1.1
24/10/2023 16:25:20 125 165 XLON 00375230984TRLO0.1.1
24/10/2023 16:29:39 165 165.4 TRQX 00375232845TRLO0.1.1
24/10/2023 16:29:39 130 165.4 TRQX 00375232846TRLO0.1.1
24/10/2023 16:29:40 418 164.8 BATE 00375232847TRLO0.1.1
24/10/2023 16:29:49 89 165.4 TRQX 00375232994TRLO0.1.1
24/10/2023 16:29:56 631 165 XLON 00375233077TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFVTIDLSFIVRecent news on Puretech Health
See all newsREG - PureTech Health PLC - Total Voting Rights
AnnouncementREG - PureTech Health PLC - Final Results
AnnouncementREG - PureTech Health PLC - Notice of Results
AnnouncementRCS - PureTech Health PLC - PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
AnnouncementRCS - PureTech Health PLC - FDA Grants PRTC's LYT-200 Fast Track Designation
Announcement